Intrapleural Tenecteplase Therapy in Treatment of Loculated Parapneumonic Pleural Effusions and Empyema
Background: Thoracic empyema (TE) and loculated parapneumonic effusions (CPE) cause considerable morbidity and mortality, with an estimated case-fatality rate of 15%. Intrapleural administration of recombinant tissue plasminogen activators (r-TPA) such as tenecteplase (TNKase) has been recently empl...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2014-10-01
|
Series: | Egyptian Journal of Chest Disease and Tuberculosis |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0422763814001526 |